Cripto-1 inhibits β-casein expression in mammary epithelial cells through a p21(ras)-and phosphatidylinositol 3'-kinase-dependent pathway

Marta L. De Santis, Subha Kannan, Gilbert H. Smith, Masaharu Seno, Caterina Bianco, Nancy Kim, Isabel Martinez-Lacaci, Brenda Wallace-Jones, David S. Salomon

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Cripto-1 (CR-1) is a recently discovered protein of the epidermal growth factor family that does not directly activate any of the known erbB type 1 tyrosine kinase receptors. Also, CR-1 stimulates the growth of HC-11 mouse mammary epithelial cells. We found that prior treatment of HC-11 cells with exogenous CR-1 induced a competency response to the lactogenic hormones dexamethasone, insulin, and prolactin (DIP) with respect to the induction of the milk protein β-casein. In contrast, simultaneous treatment of mouse HC- 11 cells with CR-1 in the presence of DIP inhibited β-casein expression. The inhibitory effects of CR-1 on β-casein expression in response to DIP were not unique to this mouse mammary epithelial cell line, because β-casein and whey acidic protein expression in primary mouse mammary explant cultures established from midpregnant mice were also differentially inhibited by several epidermal growth factor-related peptides including CR-1. The mitogenic and differentiation effects of CR-1 are mediated by the binding of CR-1 to a cell surface receptor that is known to activate the ras/raf/mitogen-activated protein kinase (MAPK)/MAPK kinase pathway. The inhibitory response of CR-1 in HC-11 cells on β-casein expression after treatment with DIP can be attenuated by B581, a peptidomimetic farnesyltransferase inhibitor that blocks p21(ras) farnesylation and activation, and by the phosphatidylinositol 3'-kinase (PI3k) inhibitor LY 294002 but not by PD 98059, a MAPK kinase inhibitor that blocks MAPK activation. These data suggest that the ability of CR-1 to block lactogenic hormone-induced expression of β-casein is mediated through a p21(ras)- dependent, PI3k-mediated pathway. This is further substantiated by the observation that CR-1 is able to stimulate the tyrosine phosphorylation of the p85 PI3k regulatory subunit and to increase the activity of PI3k in HC- 11 cells.

Original languageEnglish
Pages (from-to)1257-1266
Number of pages10
JournalCell Growth and Differentiation
Volume8
Issue number12
Publication statusPublished - Dec 1997

Fingerprint

Phosphatidylinositol 3-Kinase
Proto-Oncogene Proteins p21(ras)
Caseins
Breast
Epithelial Cells
Prolactin
Dexamethasone
Insulin
Mitogen-Activated Protein Kinases
Epidermal Growth Factor
Hormones
Farnesyltranstransferase
Peptidomimetics
Prenylation
MAP Kinase Kinase Kinases
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Milk Proteins
Mitogen-Activated Protein Kinase Kinases
Receptor Protein-Tyrosine Kinases
Cell Surface Receptors

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Cripto-1 inhibits β-casein expression in mammary epithelial cells through a p21(ras)-and phosphatidylinositol 3'-kinase-dependent pathway. / De Santis, Marta L.; Kannan, Subha; Smith, Gilbert H.; Seno, Masaharu; Bianco, Caterina; Kim, Nancy; Martinez-Lacaci, Isabel; Wallace-Jones, Brenda; Salomon, David S.

In: Cell Growth and Differentiation, Vol. 8, No. 12, 12.1997, p. 1257-1266.

Research output: Contribution to journalArticle

De Santis, ML, Kannan, S, Smith, GH, Seno, M, Bianco, C, Kim, N, Martinez-Lacaci, I, Wallace-Jones, B & Salomon, DS 1997, 'Cripto-1 inhibits β-casein expression in mammary epithelial cells through a p21(ras)-and phosphatidylinositol 3'-kinase-dependent pathway', Cell Growth and Differentiation, vol. 8, no. 12, pp. 1257-1266.
De Santis, Marta L. ; Kannan, Subha ; Smith, Gilbert H. ; Seno, Masaharu ; Bianco, Caterina ; Kim, Nancy ; Martinez-Lacaci, Isabel ; Wallace-Jones, Brenda ; Salomon, David S. / Cripto-1 inhibits β-casein expression in mammary epithelial cells through a p21(ras)-and phosphatidylinositol 3'-kinase-dependent pathway. In: Cell Growth and Differentiation. 1997 ; Vol. 8, No. 12. pp. 1257-1266.
@article{c339faeb294b48a18156bfdfb03514d5,
title = "Cripto-1 inhibits β-casein expression in mammary epithelial cells through a p21(ras)-and phosphatidylinositol 3'-kinase-dependent pathway",
abstract = "Cripto-1 (CR-1) is a recently discovered protein of the epidermal growth factor family that does not directly activate any of the known erbB type 1 tyrosine kinase receptors. Also, CR-1 stimulates the growth of HC-11 mouse mammary epithelial cells. We found that prior treatment of HC-11 cells with exogenous CR-1 induced a competency response to the lactogenic hormones dexamethasone, insulin, and prolactin (DIP) with respect to the induction of the milk protein β-casein. In contrast, simultaneous treatment of mouse HC- 11 cells with CR-1 in the presence of DIP inhibited β-casein expression. The inhibitory effects of CR-1 on β-casein expression in response to DIP were not unique to this mouse mammary epithelial cell line, because β-casein and whey acidic protein expression in primary mouse mammary explant cultures established from midpregnant mice were also differentially inhibited by several epidermal growth factor-related peptides including CR-1. The mitogenic and differentiation effects of CR-1 are mediated by the binding of CR-1 to a cell surface receptor that is known to activate the ras/raf/mitogen-activated protein kinase (MAPK)/MAPK kinase pathway. The inhibitory response of CR-1 in HC-11 cells on β-casein expression after treatment with DIP can be attenuated by B581, a peptidomimetic farnesyltransferase inhibitor that blocks p21(ras) farnesylation and activation, and by the phosphatidylinositol 3'-kinase (PI3k) inhibitor LY 294002 but not by PD 98059, a MAPK kinase inhibitor that blocks MAPK activation. These data suggest that the ability of CR-1 to block lactogenic hormone-induced expression of β-casein is mediated through a p21(ras)- dependent, PI3k-mediated pathway. This is further substantiated by the observation that CR-1 is able to stimulate the tyrosine phosphorylation of the p85 PI3k regulatory subunit and to increase the activity of PI3k in HC- 11 cells.",
author = "{De Santis}, {Marta L.} and Subha Kannan and Smith, {Gilbert H.} and Masaharu Seno and Caterina Bianco and Nancy Kim and Isabel Martinez-Lacaci and Brenda Wallace-Jones and Salomon, {David S.}",
year = "1997",
month = "12",
language = "English",
volume = "8",
pages = "1257--1266",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Cripto-1 inhibits β-casein expression in mammary epithelial cells through a p21(ras)-and phosphatidylinositol 3'-kinase-dependent pathway

AU - De Santis, Marta L.

AU - Kannan, Subha

AU - Smith, Gilbert H.

AU - Seno, Masaharu

AU - Bianco, Caterina

AU - Kim, Nancy

AU - Martinez-Lacaci, Isabel

AU - Wallace-Jones, Brenda

AU - Salomon, David S.

PY - 1997/12

Y1 - 1997/12

N2 - Cripto-1 (CR-1) is a recently discovered protein of the epidermal growth factor family that does not directly activate any of the known erbB type 1 tyrosine kinase receptors. Also, CR-1 stimulates the growth of HC-11 mouse mammary epithelial cells. We found that prior treatment of HC-11 cells with exogenous CR-1 induced a competency response to the lactogenic hormones dexamethasone, insulin, and prolactin (DIP) with respect to the induction of the milk protein β-casein. In contrast, simultaneous treatment of mouse HC- 11 cells with CR-1 in the presence of DIP inhibited β-casein expression. The inhibitory effects of CR-1 on β-casein expression in response to DIP were not unique to this mouse mammary epithelial cell line, because β-casein and whey acidic protein expression in primary mouse mammary explant cultures established from midpregnant mice were also differentially inhibited by several epidermal growth factor-related peptides including CR-1. The mitogenic and differentiation effects of CR-1 are mediated by the binding of CR-1 to a cell surface receptor that is known to activate the ras/raf/mitogen-activated protein kinase (MAPK)/MAPK kinase pathway. The inhibitory response of CR-1 in HC-11 cells on β-casein expression after treatment with DIP can be attenuated by B581, a peptidomimetic farnesyltransferase inhibitor that blocks p21(ras) farnesylation and activation, and by the phosphatidylinositol 3'-kinase (PI3k) inhibitor LY 294002 but not by PD 98059, a MAPK kinase inhibitor that blocks MAPK activation. These data suggest that the ability of CR-1 to block lactogenic hormone-induced expression of β-casein is mediated through a p21(ras)- dependent, PI3k-mediated pathway. This is further substantiated by the observation that CR-1 is able to stimulate the tyrosine phosphorylation of the p85 PI3k regulatory subunit and to increase the activity of PI3k in HC- 11 cells.

AB - Cripto-1 (CR-1) is a recently discovered protein of the epidermal growth factor family that does not directly activate any of the known erbB type 1 tyrosine kinase receptors. Also, CR-1 stimulates the growth of HC-11 mouse mammary epithelial cells. We found that prior treatment of HC-11 cells with exogenous CR-1 induced a competency response to the lactogenic hormones dexamethasone, insulin, and prolactin (DIP) with respect to the induction of the milk protein β-casein. In contrast, simultaneous treatment of mouse HC- 11 cells with CR-1 in the presence of DIP inhibited β-casein expression. The inhibitory effects of CR-1 on β-casein expression in response to DIP were not unique to this mouse mammary epithelial cell line, because β-casein and whey acidic protein expression in primary mouse mammary explant cultures established from midpregnant mice were also differentially inhibited by several epidermal growth factor-related peptides including CR-1. The mitogenic and differentiation effects of CR-1 are mediated by the binding of CR-1 to a cell surface receptor that is known to activate the ras/raf/mitogen-activated protein kinase (MAPK)/MAPK kinase pathway. The inhibitory response of CR-1 in HC-11 cells on β-casein expression after treatment with DIP can be attenuated by B581, a peptidomimetic farnesyltransferase inhibitor that blocks p21(ras) farnesylation and activation, and by the phosphatidylinositol 3'-kinase (PI3k) inhibitor LY 294002 but not by PD 98059, a MAPK kinase inhibitor that blocks MAPK activation. These data suggest that the ability of CR-1 to block lactogenic hormone-induced expression of β-casein is mediated through a p21(ras)- dependent, PI3k-mediated pathway. This is further substantiated by the observation that CR-1 is able to stimulate the tyrosine phosphorylation of the p85 PI3k regulatory subunit and to increase the activity of PI3k in HC- 11 cells.

UR - http://www.scopus.com/inward/record.url?scp=0031441627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031441627&partnerID=8YFLogxK

M3 - Article

C2 - 9419414

AN - SCOPUS:0031441627

VL - 8

SP - 1257

EP - 1266

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 12

ER -